Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 21 Aug 2024

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing

in Cancer Immunity and Immunotherapy

Ding-ming Song
Tong Shen
Kun Feng
Yi-bo He
Shi-liang Chen
Yang Zhang
Wen-fei Luo
Lu Han
Ming Tong
Yanyang Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419126

3,048 views

Review

Published on 21 Aug 2024

Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers

in Cancer Immunity and Immunotherapy

Ana Montero-Calle
María Garranzo-Asensio
Maria Teresa Moreno-Casbas
Susana Campuzano
Rodrigo Barderas

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455602

2,548 views
1 citation

Original Research

Published on 21 Aug 2024

AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

in Cancer Immunity and Immunotherapy

Austin Rayford
Fabian Gärtner
Maria P. Ramnefjell
James B. Lorens
David R. Micklem
Marianne Aanerud
Agnete S. T. Engelsen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444007

2,519 views
2 citations

Original Research

Published on 21 Aug 2024

TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Zilong Chen
Haoxi Cai
Weiwei Ye
Junming Wu
Jing Liu
Yun Xie
Shiqiang Feng
Yuanpei Jin
Yunxia Lv
Hui Ye

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445472

2,662 views

Review

Published on 21 Aug 2024

Immunotherapy for colorectal cancer

in Cancer Immunity and Immunotherapy

Bing Yu
Jian Kang
Hong Lei
Zhe Li
Hao Yang
Meng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433315

3,675 views
2 citations

Review

Published on 21 Aug 2024

Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Shuyan Dong
Ming Zhao
Jin Zhu
Ting Li
Mingze Yan
Kaixun Xing
Peng Liu
Shan Yu
Jian Ma
Hongjiang He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442673

2,159 views

Original Research

Published on 21 Aug 2024

Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity

in Cancer Immunity and Immunotherapy

Tatiana Akimova
Liqing Wang
Zhanna Bartosh
Lanette M. Christensen
Evgeniy Eruslanov
Sunil Singhal
Veenu Aishwarya
Wayne W. Hancock

Frontiers in Immunology

doi 10.3389/fimmu.2024.1426657

2,155 views
1 citation

Editorial

Published on 21 Aug 2024

Editorial: Women in cancer immunity and immunotherapy

in Cancer Immunity and Immunotherapy

Min Yao
Evelyn Ullrich
Adriana Albini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466010

829 views

Case Report

Published on 21 Aug 2024

Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review

in Cancer Immunity and Immunotherapy

Xiaoxuan Li
Xinchi Luan
Mengqi Zhang
Rui Wang
Jing Guo
Jing Lv
Wensheng Qiu
Shufen Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439033

2,699 views

Original Research

Published on 21 Aug 2024

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4

in Cancer Immunity and Immunotherapy

Doris K. Hansen
Xiaoxiao Lu
Omar Castaneda Puglianini
Sonja Sorensen
Saad Z. Usmani
Eileen Zhang
Stephen Huo
Yan Zhang
Zaina P. Qureshi
Sundar Jagannath

Frontiers in Immunology

doi 10.3389/fimmu.2024.1408892

3,646 views

Review

Published on 21 Aug 2024

An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies

in Cancer Immunity and Immunotherapy

David Dejardin
Anton Kraxner
Emilie Schindler
Nicolas Städler
Marcel Wolbers

Frontiers in Immunology

doi 10.3389/fimmu.2024.1351584

1,541 views
2 citations

Original Research

Published on 21 Aug 2024

Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study

in Cancer Immunity and Immunotherapy

Fábio Magalhães-Gama
Marina Malheiros Araújo Silvestrini
Juliana Costa Ferreira Neves
Nilberto Dias Araújo
Fabíola Silva Alves-Hanna
Marlon Wendell Athaydes Kerr
Maria Perpétuo Socorro Sampaio Carvalho
Andréa Monteiro Tarragô
Gemilson Soares Pontes
Olindo Assis Martins-Filho

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421036

3,183 views

Review

Published on 20 Aug 2024

A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application

in Cancer Immunity and Immunotherapy

Wenyue Cheng
Ningning Zhu
Juanjuan Wang
Rongcun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1331518

2,278 views

Review

Published on 20 Aug 2024

Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape

in Cancer Immunity and Immunotherapy

Silvia González-Martínez
Belén Pérez-Mies
Javier Cortés
José Palacios

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425212

3,517 views
1 citation

Original Research

Published on 20 Aug 2024

Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database

in Cancer Immunity and Immunotherapy

Mingming Yu
Lijun Zhou
Mengda Cao
Chunmei Ji
Yuanyi Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397692

2,667 views
1 citation

Review

Published on 20 Aug 2024

The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications

in Cancer Immunity and Immunotherapy

Jin-Xiu Liu
Xiaoping Zhang
Wen-Hua Xu
Xiao-Dan Hao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439485

1,760 views
1 citation

Navigation group

Articles

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing

Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers

AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma

Immunotherapy for colorectal cancer

Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma

Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity

Editorial: Women in cancer immunity and immunotherapy

Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4

An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies

Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study

A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application

Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape

Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database

The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications